Disc Medicine Inc. IRON
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Disc Medicine Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It targets fundamental biological pathways associated with the formation and function of red blood cells, particularly heme biosynthesis and iron ho…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees154
TickerIRON
Statistics
Market Cap$2.68B
Revenue (TTM)$0
Net Income-$212.2M
Net Margin—
EPS$-6.01
P/E4.99
P/S—
P/B3.73
EV/EBITDA-7.07
ROE-35.8%
Dividend Yield—
Price$70.24
Data: Twelve Data · Revenue = mcap / P/S